Corydalis is a flowering plant used for centuries in traditional Chinese medicine primarily as a natural pain reliever. Its root extract contains compounds that act on pain signaling pathways in the brain, and modern research has begun to clarify how those compounds work and which types of pain they address best. The plant grows in Siberia, Northern China, and Japan, and its dried root (or tuber) is the part used medicinally.
Pain Relief Is the Primary Use
Corydalis has the strongest evidence as an analgesic. People have traditionally used it for menstrual cramps, chest pain, abdominal pain, and headaches. Research now shows its pain-relieving effects extend to two major categories: inflammatory pain (linked to tissue damage and immune cell activity) and neuropathic pain (caused by damage to the nervous system itself). That dual action is notable because many conventional painkillers work well for one type but not both.
In a study of people with stomach and intestinal ulcers or chronic inflammation of the stomach lining, 90 to 120 mg of corydalis extract per day was effective in 76% of participants. That dose was equivalent to roughly 5 to 10 grams of the crude dried herb.
How It Works in the Body
Researchers at UC Irvine, working with Chinese scientists, screened nearly 500 compounds from 10 traditional Chinese medicines known for pain relief. Only one compound produced a reliable, reproducible analgesic effect: dehydrocorybulbine, or DHCB, extracted from the corydalis root.
DHCB works partly by blocking dopamine D2 receptors in the brain. When researchers tested the compound in mice that had been genetically engineered to lack D2 receptors, the pain-relieving effects were significantly reduced for acute and neuropathic pain, confirming that D2 receptor blockade is a key part of the mechanism. DHCB also interacts with a second set of receptors called P2X receptors, which are involved in how sensory neurons transmit pain signals from damaged tissue to the brain.
One particularly promising finding: DHCB did not produce the tolerance that develops with continued use of conventional painkillers like morphine. With most opioid-based medications, patients need progressively higher doses to get the same relief. DHCB maintained its effectiveness without that escalation in animal studies.
Specific Conditions It May Help
Beyond general pain relief, corydalis has traditional and emerging uses for several conditions:
- Menstrual cramps. One of its oldest and most common applications. The antispasmodic and analgesic properties of the root extract target the abdominal pain associated with menstruation.
- Headaches. Corydalis has been used for headache relief in traditional practice, and its mechanism of action on dopamine receptors is consistent with how certain headache medications work.
- Epigastric and abdominal pain. Pain in the upper stomach area and general abdominal discomfort are among the conditions with the most traditional support, backed by the ulcer study showing a 76% response rate.
- Nerve pain. Animal models of nerve injury show that corydalis compounds reduce neuropathic pain, which is the burning, shooting, or tingling pain that results from nerve damage. This type of pain is notoriously difficult to treat with standard medications.
- Sedation and sleep. Corydalis has mild sedative properties, which is why the dried rhizome is sometimes recommended specifically for calming effects alongside pain relief.
Typical Dosage and Forms
Corydalis is available as a crude dried root, a liquid extract, and in capsule or tablet form. For pain relief or sedation, the standard recommendation for the crude dried rhizome is 5 to 10 grams per day. As a liquid tincture (1:2 concentration), the typical range is 10 to 20 ml per day. Standardized extract capsules generally contain a concentrated equivalent of the crude herb, with the ulcer study using 90 to 120 mg of extract daily.
One branded supplement called Motilitone, which combines corydalis with other ingredients, has been used in studies at a dose of three times daily before meals for up to four weeks. However, reliable dosing information for corydalis taken alone in supplement form is still limited.
Safety and Side Effects
Corydalis is generally well tolerated at traditional doses, but it carries a real risk of liver injury that deserves attention. One of its active compounds, tetrahydropalmatine, has been linked to hepatotoxicity. Case reports have documented liver damage in people taking corydalis supplements, with elevated liver enzymes appearing during use and resolving after the supplement was stopped. The compound was previously implicated in liver problems associated with another Chinese herbal product called Jin Bu Huan.
Because corydalis acts on the central nervous system and has sedative properties, it can amplify the effects of other sedating substances. Combining it with alcohol, prescription sleep aids, or anti-anxiety medications increases the risk of excessive drowsiness. If you take antidepressants or other medications that affect brain chemistry, the potential for interaction is worth discussing with a healthcare provider before starting corydalis.
People with liver disease or those taking medications processed by the liver should be particularly cautious. The lack of standardized manufacturing for herbal supplements means that potency and purity can vary significantly between products, which makes dosing less predictable than with pharmaceutical-grade medications.
How It Compares to Conventional Pain Relief
Corydalis occupies an interesting middle ground. It is not as potent as opioid painkillers for severe acute pain, but its lack of tolerance buildup gives it a potential advantage for people dealing with chronic, ongoing pain. The fact that it addresses both inflammatory and neuropathic pain through mechanisms distinct from opioids makes it a complement rather than a direct substitute.
Its dopamine-based mechanism is different from how NSAIDs (like ibuprofen) or acetaminophen work, which means it could theoretically be useful for pain that doesn’t respond well to over-the-counter options. That said, the clinical evidence in humans is still thinner than what exists for conventional medications. Most of the mechanistic research comes from animal models, and large-scale human trials are limited.